Does the media favor AMS or CTEC?

In the previous week, ConvaTec Group had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 2 mentions for ConvaTec Group and 1 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 0.45 beat ConvaTec Group's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Advanced Medical Solutions Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ConvaTec Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings & valuation, TSTL or CTEC?

ConvaTec Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Tristel £49.54M 3.78 £6.54M £16.24 24.01 ConvaTec Group £2.44B 1.66 £188.35M £8.60 24.04

Is TSTL or CTEC more profitable?

Tristel has a net margin of 15.88% compared to ConvaTec Group's net margin of 7.17%. Tristel's return on equity of 23.64% beat ConvaTec Group's return on equity. Company Net Margins Return on Equity Return on Assets Tristel 15.88% 23.64% 9.89% ConvaTec Group 7.17% 10.53% 5.01%

Does the media prefer TSTL or CTEC?

In the previous week, ConvaTec Group had 1 more articles in the media than Tristel. MarketBeat recorded 2 mentions for ConvaTec Group and 1 mentions for Tristel. Tristel's average media sentiment score of 0.00 equaled ConvaTec Group'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tristel 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral ConvaTec Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer SPEC or CTEC?

In the previous week, INSPECS Group and INSPECS Group both had 2 articles in the media. INSPECS Group's average media sentiment score of 0.18 beat ConvaTec Group's score of 0.00 indicating that INSPECS Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment INSPECS Group 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral ConvaTec Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate CTEC or BVC?

ConvaTec Group currently has a consensus price target of GBX 306, indicating a potential upside of 48.03%. Given ConvaTec Group's stronger consensus rating and higher probable upside, research analysts clearly believe ConvaTec Group is more favorable than BATM Advanced Communications. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ConvaTec Group 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 BATM Advanced Communications 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Does the media refer more to CTEC or BVC?

In the previous week, BATM Advanced Communications had 1 more articles in the media than ConvaTec Group. MarketBeat recorded 3 mentions for BATM Advanced Communications and 2 mentions for ConvaTec Group. BATM Advanced Communications' average media sentiment score of 0.86 beat ConvaTec Group's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ConvaTec Group 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BATM Advanced Communications 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer AKR or CTEC?

ConvaTec Group has a consensus target price of GBX 306, indicating a potential upside of 48.03%. Given ConvaTec Group's stronger consensus rating and higher possible upside, analysts plainly believe ConvaTec Group is more favorable than Akers Biosciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Akers Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 ConvaTec Group 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89

ConvaTec Group (CTEC) Competitors

GBX 206.71 -0.69 (-0.33%)

As of 12:37 PM Eastern

Compare

CTEC vs. AMS, TSTL, SPEC, BVC, and AKR

Should you buy ConvaTec Group stock or one of its competitors? MarketBeat compares ConvaTec Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ConvaTec Group include Advanced Medical Solutions Group (AMS), Tristel (TSTL), INSPECS Group (SPEC), BATM Advanced Communications (BVC), and Akers Biosciences (AKR). These companies are all part of the "medical instruments & supplies" industry.

How does ConvaTec Group compare to Advanced Medical Solutions Group?

Advanced Medical Solutions Group (LON:AMS) and ConvaTec Group (LON:CTEC) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership.

Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.1%. ConvaTec Group pays an annual dividend of GBX 6.77 per share and has a dividend yield of 3.3%. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend. ConvaTec Group pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, ConvaTec Group had 1 more articles in the media than Advanced Medical Solutions Group. MarketBeat recorded 2 mentions for ConvaTec Group and 1 mentions for Advanced Medical Solutions Group. Advanced Medical Solutions Group's average media sentiment score of 0.45 beat ConvaTec Group's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Advanced Medical Solutions Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ConvaTec Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Advanced Medical Solutions Group has a beta of 0.709, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, ConvaTec Group has a beta of 0.756, suggesting that its stock price is 24% less volatile than the broader market.

Advanced Medical Solutions Group presently has a consensus price target of GBX 270.25, suggesting a potential upside of 11.07%. ConvaTec Group has a consensus price target of GBX 306, suggesting a potential upside of 48.03%. Given ConvaTec Group's stronger consensus rating and higher possible upside, analysts clearly believe ConvaTec Group is more favorable than Advanced Medical Solutions Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Medical Solutions Group	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

21.9% of Advanced Medical Solutions Group shares are owned by institutional investors. Comparatively, 68.1% of ConvaTec Group shares are owned by institutional investors. 4.0% of Advanced Medical Solutions Group shares are owned by company insiders. Comparatively, 1.0% of ConvaTec Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

ConvaTec Group has higher revenue and earnings than Advanced Medical Solutions Group. ConvaTec Group is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Medical Solutions Group	£228.94M	2.31	£11.22M	£4.52	53.83
ConvaTec Group	£2.44B	1.66	£188.35M	£8.60	24.04

ConvaTec Group has a net margin of 7.17% compared to Advanced Medical Solutions Group's net margin of 4.35%. ConvaTec Group's return on equity of 10.53% beat Advanced Medical Solutions Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Medical Solutions Group	4.35%	3.87%	2.35%
ConvaTec Group	7.17%	10.53%	5.01%

Summary

ConvaTec Group beats Advanced Medical Solutions Group on 13 of the 18 factors compared between the two stocks.

How does ConvaTec Group compare to Tristel?

Tristel (LON:TSTL) and ConvaTec Group (LON:CTEC) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Tristel has a net margin of 15.88% compared to ConvaTec Group's net margin of 7.17%. Tristel's return on equity of 23.64% beat ConvaTec Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tristel	15.88%	23.64%	9.89%
ConvaTec Group	7.17%	10.53%	5.01%

In the previous week, ConvaTec Group had 1 more articles in the media than Tristel. MarketBeat recorded 2 mentions for ConvaTec Group and 1 mentions for Tristel. Tristel's average media sentiment score of 0.00 equaled ConvaTec Group'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tristel	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
ConvaTec Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

ConvaTec Group has higher revenue and earnings than Tristel. Tristel is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tristel	£49.54M	3.78	£6.54M	£16.24	24.01
ConvaTec Group	£2.44B	1.66	£188.35M	£8.60	24.04

Tristel presently has a consensus price target of GBX 400, indicating a potential upside of 2.56%. ConvaTec Group has a consensus price target of GBX 306, indicating a potential upside of 48.03%. Given ConvaTec Group's stronger consensus rating and higher probable upside, analysts plainly believe ConvaTec Group is more favorable than Tristel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tristel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

Tristel has a beta of 0.333, suggesting that its stock price is 67% less volatile than the broader market. Comparatively, ConvaTec Group has a beta of 0.756, suggesting that its stock price is 24% less volatile than the broader market.

Tristel pays an annual dividend of GBX 14.20 per share and has a dividend yield of 3.6%. ConvaTec Group pays an annual dividend of GBX 6.77 per share and has a dividend yield of 3.3%. Tristel pays out 87.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ConvaTec Group pays out 78.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

21.6% of Tristel shares are held by institutional investors. Comparatively, 68.1% of ConvaTec Group shares are held by institutional investors. 21.0% of Tristel shares are held by company insiders. Comparatively, 1.0% of ConvaTec Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

ConvaTec Group beats Tristel on 10 of the 17 factors compared between the two stocks.

How does ConvaTec Group compare to INSPECS Group?

INSPECS Group (LON:SPEC) and ConvaTec Group (LON:CTEC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, analyst recommendations, institutional ownership and media sentiment.

ConvaTec Group has higher revenue and earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
INSPECS Group	£191.70M	0.53	-£4.11M	-£9.40	N/A
ConvaTec Group	£2.44B	1.66	£188.35M	£8.60	24.04

INSPECS Group presently has a consensus target price of GBX 60, suggesting a potential downside of 40.00%. ConvaTec Group has a consensus target price of GBX 306, suggesting a potential upside of 48.03%. Given ConvaTec Group's higher possible upside, analysts plainly believe ConvaTec Group is more favorable than INSPECS Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
INSPECS Group	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

ConvaTec Group has a net margin of 7.17% compared to INSPECS Group's net margin of -2.67%. ConvaTec Group's return on equity of 10.53% beat INSPECS Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
INSPECS Group	-2.67%	-6.07%	0.45%
ConvaTec Group	7.17%	10.53%	5.01%

0.4% of INSPECS Group shares are held by institutional investors. Comparatively, 68.1% of ConvaTec Group shares are held by institutional investors. 21.0% of INSPECS Group shares are held by company insiders. Comparatively, 1.0% of ConvaTec Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, INSPECS Group and INSPECS Group both had 2 articles in the media. INSPECS Group's average media sentiment score of 0.18 beat ConvaTec Group's score of 0.00 indicating that INSPECS Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
INSPECS Group	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
ConvaTec Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

INSPECS Group has a beta of 1.611, meaning that its stock price is 61% more volatile than the broader market. Comparatively, ConvaTec Group has a beta of 0.756, meaning that its stock price is 24% less volatile than the broader market.

Summary

ConvaTec Group beats INSPECS Group on 11 of the 15 factors compared between the two stocks.

How does ConvaTec Group compare to BATM Advanced Communications?

ConvaTec Group (LON:CTEC) and BATM Advanced Communications (LON:BVC) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

68.1% of ConvaTec Group shares are held by institutional investors. Comparatively, 16.6% of BATM Advanced Communications shares are held by institutional investors. 1.0% of ConvaTec Group shares are held by company insiders. Comparatively, 31.0% of BATM Advanced Communications shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

ConvaTec Group has a net margin of 7.17% compared to BATM Advanced Communications' net margin of -14.90%. ConvaTec Group's return on equity of 10.53% beat BATM Advanced Communications' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ConvaTec Group	7.17%	10.53%	5.01%
BATM Advanced Communications	-14.90%	-22.13%	0.58%

In the previous week, BATM Advanced Communications had 1 more articles in the media than ConvaTec Group. MarketBeat recorded 3 mentions for BATM Advanced Communications and 2 mentions for ConvaTec Group. BATM Advanced Communications' average media sentiment score of 0.86 beat ConvaTec Group's score of 0.00 indicating that BATM Advanced Communications is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ConvaTec Group	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
BATM Advanced Communications	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

ConvaTec Group has higher revenue and earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ConvaTec Group	£2.44B	1.66	£188.35M	£8.60	24.04
BATM Advanced Communications	£123.20M	0.41	-£278.26K	-£4.20	N/A

ConvaTec Group has a beta of 0.756, meaning that its share price is 24% less volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.75, meaning that its share price is 25% less volatile than the broader market.

ConvaTec Group currently has a consensus price target of GBX 306, indicating a potential upside of 48.03%. Given ConvaTec Group's stronger consensus rating and higher probable upside, research analysts clearly believe ConvaTec Group is more favorable than BATM Advanced Communications.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89
BATM Advanced Communications	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

ConvaTec Group beats BATM Advanced Communications on 13 of the 16 factors compared between the two stocks.

How does ConvaTec Group compare to Akers Biosciences?

Akers Biosciences (LON:AKR) and ConvaTec Group (LON:CTEC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends.

In the previous week, ConvaTec Group had 2 more articles in the media than Akers Biosciences. MarketBeat recorded 2 mentions for ConvaTec Group and 0 mentions for Akers Biosciences. Akers Biosciences' average media sentiment score of 0.00 equaled ConvaTec Group'saverage media sentiment score.

Company	Overall Sentiment
Akers Biosciences	Neutral
ConvaTec Group	Neutral

68.1% of ConvaTec Group shares are owned by institutional investors. 1.0% of ConvaTec Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

ConvaTec Group has higher revenue and earnings than Akers Biosciences. Akers Biosciences is trading at a lower price-to-earnings ratio than ConvaTec Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Akers Biosciences	£2.32M	0.00	N/A	-£129.60	N/A
ConvaTec Group	£2.44B	1.66	£188.35M	£8.60	24.04

ConvaTec Group has a net margin of 7.17% compared to Akers Biosciences' net margin of 0.00%. ConvaTec Group's return on equity of 10.53% beat Akers Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Akers Biosciences	N/A	N/A	N/A
ConvaTec Group	7.17%	10.53%	5.01%

ConvaTec Group has a consensus target price of GBX 306, indicating a potential upside of 48.03%. Given ConvaTec Group's stronger consensus rating and higher possible upside, analysts plainly believe ConvaTec Group is more favorable than Akers Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Akers Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
ConvaTec Group	0 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.89

Summary

ConvaTec Group beats Akers Biosciences on 12 of the 12 factors compared between the two stocks.

Get ConvaTec Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CTEC vs. The Competition

Export

Metric	ConvaTec Group	Medical Instruments & Supplies Industry	Medical Sector	LON Exchange
Market Cap	£4.04B	£2.85B	£6.48B	£2.78B
Dividend Yield	2.60%	2.01%	2.68%	6.16%
P/E Ratio	24.04	16.31	24.66	365.72
Price / Sales	1.66	74.09	529.89	86,253.73
Price / Cash	17.01	146.54	27.92	27.85
Price / Book	2.58	2.21	10.84	7.93
Net Income	£188.35M	£99.80M	£3.56B	£5.89B
7 Day Performance	-1.65%	-0.99%	1.71%	-0.87%
1 Month Performance	4.93%	-1.99%	0.48%	-0.76%
1 Year Performance	-28.67%	-8.16%	32.98%	70.67%

ConvaTec Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CTEC ConvaTec Group	4.5332 of 5 stars	GBX 206.71 -0.3%	GBX 306 +48.0%	-26.7%	£4.04B	£2.44B	24.04	10,000	News Coverage
AMS Advanced Medical Solutions Group	1.5526 of 5 stars	GBX 227 +5.6%	GBX 270.25 +19.1%	+11.6%	£493.11M	£228.94M	50.22	10	News Coverage Positive News
TSTL Tristel	0.8009 of 5 stars	GBX 383.60 -0.4%	GBX 400 +4.3%	+6.3%	£184.07M	£49.54M	23.62	208	News Coverage
SPEC INSPECS Group	0.9477 of 5 stars	GBX 98 +16.0%	GBX 60 -38.8%	+101.0%	£99.64M	£191.70M	N/A	1,673	Gap Down
BVC BATM Advanced Communications	N/A	GBX 14.25 +2.5%	N/A	-8.8%	£48.46M	£123.20M	N/A	980	News Coverage Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:CTEC) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ConvaTec Group (CTEC) Competitors

CTEC vs. AMS, TSTL, SPEC, BVC, and AKR

How does ConvaTec Group compare to Advanced Medical Solutions Group?

Summary

How does ConvaTec Group compare to Tristel?

Summary

How does ConvaTec Group compare to INSPECS Group?

Summary

How does ConvaTec Group compare to BATM Advanced Communications?

Summary

How does ConvaTec Group compare to Akers Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTEC vs. The Competition

ConvaTec Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ConvaTec Group (CTEC) Competitors

CTEC vs. AMS, TSTL, SPEC, BVC, and AKR

How does ConvaTec Group compare to Advanced Medical Solutions Group?

Is AMS or CTEC a better dividend stock?

Does the media favor AMS or CTEC?

Which has more volatility & risk, AMS or CTEC?

Do analysts rate AMS or CTEC?

Do insiders & institutionals have more ownership in AMS or CTEC?

Which has higher earnings and valuation, AMS or CTEC?

Is AMS or CTEC more profitable?

Summary

How does ConvaTec Group compare to Tristel?

Is TSTL or CTEC more profitable?

Does the media prefer TSTL or CTEC?

Which has higher earnings & valuation, TSTL or CTEC?

Do analysts recommend TSTL or CTEC?

Which has more risk & volatility, TSTL or CTEC?

Is TSTL or CTEC a better dividend stock?

Do institutionals & insiders have more ownership in TSTL or CTEC?

Summary

How does ConvaTec Group compare to INSPECS Group?

Which has stronger earnings and valuation, SPEC or CTEC?

Do analysts prefer SPEC or CTEC?

Is SPEC or CTEC more profitable?

Do insiders and institutionals hold more shares of SPEC or CTEC?

Does the media prefer SPEC or CTEC?

Which has more risk & volatility, SPEC or CTEC?

Summary

How does ConvaTec Group compare to BATM Advanced Communications?

Do institutionals & insiders believe in CTEC or BVC?

Is CTEC or BVC more profitable?

Does the media refer more to CTEC or BVC?

Which has stronger earnings and valuation, CTEC or BVC?

Which has more volatility and risk, CTEC or BVC?

Do analysts rate CTEC or BVC?

Summary

How does ConvaTec Group compare to Akers Biosciences?

Does the media refer more to AKR or CTEC?

Do insiders & institutionals have more ownership in AKR or CTEC?

Which has higher earnings and valuation, AKR or CTEC?

Is AKR or CTEC more profitable?

Do analysts prefer AKR or CTEC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CTEC vs. The Competition

ConvaTec Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools